| COVID‐19 in cancer patients on active systemic therapy–outcomes from LMIC scenario with an emphasis on need for active treatment A Ramaswamy, L Nayak, N Roy Moulik, M Sengar, G Chinnaswamy, ... Cancer Medicine 9 (23), 8747-8753, 2020 | 37 | 2020 |
| Results of phase III randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer, unsuitable for cisplatin-based chemoradiation VM Patil, V Noronha, N Menon, A Singh, S Ghosh-Laskar, A Budrukkar, ... Journal of Clinical Oncology 41 (13), 2350-2361, 2023 | 31 | 2023 |
| Immune checkpoint inhibitors in older patients with solid tumors: Real-world experience from India G Abraham, KN Jobanputra, V Noronha, VM Patil, NS Menon, SC Gattani, ... Cancer Research, Statistics, and Treatment 4 (2), 270-276, 2021 | 10 | 2021 |
| Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral … L Kashyap, V Patil, V Noronha, A Joshi, N Menon, K Jobanputra, S Saha, ... ecancermedicalscience 15, 2021 | 7 | 2021 |
| Infections in systemic lupus erythematosus AG Rajadhyaksha, K Jobanputra J Assoc Physicians India 68 (5), 18-21, 2020 | 4 | 2020 |
| Diffuse large B-cell lymphoma in the elderly: real-world outcomes from a developing country K Jobanputra, L Nayak, H Jain, T Shet, S Epari, VNA Bonda, J Thorat, ... Clinical Lymphoma Myeloma and Leukemia 22 (10), e898-e906, 2022 | 3 | 2022 |
| Phase III randomized controlled trial of gefitinib versus chemotherapy in EGFR-positive treatment-naïve metastatic lung cancer: Long-term outcome after eight years A Singh, V Patil, N Menon, S More, S Jain, S Goud, D Shah, M Shah, ... Cancer Research, Statistics, and Treatment 7 (1), 19-26, 2024 | 1 | 2024 |
| Demographic insights into head-and-neck cancers KN Jobanputra Cancer Research, Statistics, and Treatment 6 (3), 478-479, 2023 | 1 | 2023 |
| Diffuse Large B-Cell Lymphoma in the Elderly: Retrospective Analysis from a Single Tertiary Cancer Center in India KN Jobanputra, L Nayak, H Jain, M Sengar Blood 138, 2515, 2021 | 1 | 2021 |
| A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond … V Noronha, NS Menon, VM Patil, MV Chandrakanth, S More, A Dhanawat, ... JTO Clinical and Research Reports 5 (1), 100622, 2024 | | 2024 |
| Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized study V Noronha, V Patil, N Menon, D Kalra, A Singh, M Shah, S Goud, ... Medical Oncology 41 (1), 26, 2023 | | 2023 |
| 447P Quality of life in patients with EGFR-mutated lung cancer receiving gefitinib vs gefitinib plus pemetrexed and carboplatin chemotherapy NS Menon, V Noronha, OR Chowdhury, AR Pawar, VM Patil, AC Singh, ... Annals of Oncology 34, S1637, 2023 | | 2023 |
| Impact of pre-treatment anemia on survival in locally advanced head neck squamous cell carcinomas treated with radiation with or without concurrent chemotherapy. MJ Shah, VM Patil, V Noronha, NS Menon, AC Singh, KN Jobanputra, ... Journal of Clinical Oncology 41 (16_suppl), e18079-e18079, 2023 | | 2023 |
| A comparative study evaluating the quality of life in patients receiving chemotherapy versus oral TKI in the third line and beyond setting for advanced non–small-cell lung cancer. NS Menon, V Noronha, VM Patil, AC Singh, N Purandare, A Mahajan, ... Journal of Clinical Oncology 41 (16_suppl), e21195-e21195, 2023 | | 2023 |
| Poster: ABCL-322 Retrospective Analysis of Real-World Outcomes in Older Adult Patients With Diffuse Large B-Cell Lymphoma K Jobanputra, L Nayak, H Jain, VNA Bonda, J Thorat, B Bagal, M Sengar Clinical Lymphoma, Myeloma and Leukemia 22, S169, 2022 | | 2022 |
| ABCL-322 Retrospective Analysis of Real-World Outcomes in Older Adult Patients With Diffuse Large B-Cell Lymphoma K Jobanputra, L Nayak, H Jain, VNA Bonda, J Thorat, B Bagal, M Sengar Clinical Lymphoma Myeloma and Leukemia 22, S372-S373, 2022 | | 2022 |
| First year of residency: As the dust settles K Jobanputra Cancer Research, Statistics, and Treatment 3 (1), 42-43, 2020 | | 2020 |
| Authors’ reply to Jayakar and Bagal et al. H Jain, K Jobanputra, J Thorat Cancer Research, Statistics, and Treatment 3 (1), 139-140, 2020 | | 2020 |
